Institute for Advanced Medical Research

Alpharetta, Georgia 30022

0 studies enrolling now · 18 studies all time

What they study most

Adult Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Borderline Personality Disorder, Depression, Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-resistant, Generalized Anxiety Disorder, Major Depressive Disorder, Migraine, With or Without Aura, Post-Traumatic Stress Disorder

Studies at this site

• A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder — Completed
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
• A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) — Completed
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) — Completed
• A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder — Completed
• Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD — Completed
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females — Completed
• Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) — Completed
• A Study of Intermittent Doses of CERC-301 in MDD — Completed
• Open-label Safety Study in Adults With ADHD — Completed
• Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil — Stopped early
• Study of NSI-189 for Major Depressive Disorder — Status unconfirmed
• The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD — Stopped early
• POC Study in Partially Responsive Generalized Anxiety Disorder — Stopped early